OBJECTIVE: To investigate the patterns of hepatic involvement and the outcome of @entity1 with hepatic metastases from @entity2622 . METHODS: Of 1665 @entity1 with @entity2622 , 20 @entity1 with hepatic metastases were detected clinically during the course of the disease. Clinical presentation and detailed patterns of hepatic involvement were retrospectively reviewed for these @entity1 . Comparative analysis between patterns of heaptic metastases and survival data was also undertaken. RESULTS: Hepatic @entity3 from @entity2622 were nearly always accompanied by uncontrolled locoregional diseases and/or extrahepatic metastases, whereas only 1 @entity1 developed an isolated hepatic @entity3 . Ninety percent of the hepatic metastases were metachronously detected. The median time from the appearance of @entity189 to detection of hepatic metastases was 39 months, but late metastases after 5 years were not uncommon. @entity3 in 16 @entity1 consisted of @entity5 distributed in either one or both anatomical lobes, whereas only 4 @entity1 had a solitary lesion confined to a single lobe. @entity1 with hepatic metastases were unlikely to survive 2 years with a median survival of 10 months. CONCLUSION: Favorable patterns of hepatic metastases in @entity1 with @entity2622 were not major determinants of favorable survival if components of @entity6687 were concomitantly present.

Hepatic metastases from XXXX .

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'patient'] @entity5 :: ('MESH:D009369', 'Disease') :: ['multiple tumors'] @entity2622 :: ('MESH:D002583', 'Disease') :: ['carcinoma of the uterine cervix'] @entity189 :: ('MESH:D002277', 'Disease') :: ['primary carcinoma'] @entity3 :: ('MESH:D009362', 'Disease') :: ['metastasis', 'Metastatic lesion'] @entity6687 :: ('MESH:D001651', 'Disease') :: ['extrahepatic disease']
@entity2622 :: (MESH:D002583,Disease) :: ['carcinoma of the uterine cervix']
